Corey Jacobs, MD
Obstetrics & Gynecology · Elk City, OKNPI 1598790024
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 27.2% of the total. Reporting peaked in 2023 at $313 and has fallen 83.0% since, to $53 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in OK, where the typical reported total is $1,081.
Across 55 payments — averaging $20.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$304
- Astellas Pharma US Inc$143
- Boston Scientific$98
- Roche Diagnostics Corporation$95
- Next Science LLC$83
- Novo Nordisk$77
- plus $315 from 13 others
Across 2 payments — averaging $31,074 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Davol Inc.$62K
What the payments were for
- Food & beverage$1,115100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 17 | $304 |
| Astellas Pharma US Inc | 5 | $143 |
| Boston Scientific | 3 | $98 |
| Roche Diagnostics Corporation | 4 | $95 |
| Next Science LLC | 1 | $83 |
| Novo Nordisk | 5 | $77 |
| Exeltis, USA Inc. | 4 | $67 |
| Lilly USA, LLC | 3 | $41 |
| Shield Therapeutics Inc | 2 | $37 |
| Hologic Sales And Service, LLC | 2 | $30 |
| Conmed Corporation | 1 | $23 |
| Sanara Medtech Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Organon | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
| Coloplast | 1 | $14 |
| Avion Pharmaceuticals | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $8 |
How this compares
$1,115 in reported general payments places this provider in the 50th percentile of 396 obstetrics & gynecology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 19 | $137 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Elk City
- Tori OdanielOklahoma City$917K
- Kathleen MooreOklahoma City$795K
- Joseph NemcokTulsa$632K
- Jay WilliamsonTulsa$130K
- John SiegleAda$50K
- Lori HubbardTulsa$41K
- Dawn WilsonYukon$36K
- Beverly VavrickaOklahoma City$22K
- Micah RelicTulsa$20K
- Monica ReidOklahoma City$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.